A doctor who developed Guillain-Barré syndrome will consider having the swine flu jab when she returns to work this autumn, despite claims that the vaccine is linked to an increased risk of the disease.
Laura Claire Price, a specialist in respiratory and intensive care medicine, examines the reasons why the vaccine might cause the syndrome, reviews the current evidence, and concludes that she will consider having the jab when it becomes available.
“In view of the potential risks of flu infection as a healthcare professional, the lack of relapse of the syndrome in a sizeable number of people who have had the flu vaccine, and the lack of a persistent causal association, my current view is to consider having the jab when it becomes available,” she writes.
If our reporting has informed or inspired you, please consider making a donation. Every contribution, no matter the size, empowers us to continue delivering accurate, engaging, and trustworthy science and medical news. Independent journalism requires time, effort, and resources—your support ensures we can keep uncovering the stories that matter most to you.
Join us in making knowledge accessible and impactful. Thank you for standing with us!